Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;7(3):884-891.
doi: 10.1002/ehf2.12679. Epub 2020 Mar 12.

Non-invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM-HF and TIM-HF2 trials

Serdar Tütüncü  1 , Marcus Honold  2 , Kerstin Koehler  3 , Oliver Deckwart  3 , Friedrich Koehler  3 , Karl Georg Haeusler  4
Affiliations

Non-invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM-HF and TIM-HF2 trials

Serdar Tütüncü et al. ESC Heart Fail. 2020 Jun.

Abstract

Aims: Patients with chronic heart failure (CHF) have an increased risk of ischaemic stroke. We aimed to identify the incidence rate and factors associated with ischaemic stroke or transient ischaemic attack (TIA) in CHF patients as well as the impact of non-invasive telemedical care (NITC) on acute stroke/TIA.

Methods and results: We retrospectively analysed baseline characteristics of 2248 CHF patients enrolled to the prospective multicentre Telemedical Interventional Monitoring in Heart Failure study (TIM-HF) and Telemedical Interventional Management in Heart Failure II study (TIM-HF2), randomizing New York Heart Association (NYHA) II/III patients 1:1 to NITC or standard of care. Hospitalizations due to acute ischaemic stroke or TIA during a follow-up of 12 months were analysed. Old age, hyperlipidaemia, lower body mass index, and peripheral arterial occlusive disease (PAOD) were independently associated with present cerebrovascular disease on enrolment. The stroke/TIA rate was 1.5 per 100 patients-years within 12 months after randomization (n = 32, 1.4%). Rate of stroke/TIA within 12 months was in the intervention group similar compared with the control group (50.0% vs. 49.8%; P = 0.98) despite that the rate of newly detected atrial fibrillation (AF) was higher in the intervention group (14.1% vs. 1.6%; P < 0.001). A history of PAOD (OR 2.7, 95% CI 1.2-6.2; P = 0.02) and the highest tertile (OR 3.0, 95% CI 1.1-8.3) of N-terminal pro-brain natriuretic peptide (NT-proBNP) on enrolment were associated with stroke/TIA during follow-up. In patients who suffered acute stroke or TIA during follow-up, echocardiography was part of the diagnostic workup in only 56% after hospital admission.

Conclusions: Annual rate of ischaemic stroke/TIA in NYHA II/III patients is low but higher in those with elevated NT-proBNP levels and history of PAOD at baseline. NITC showed no impact on the stroke rate during 1 year follow-up despite a significantly higher rate of newly detected AF. Irrespective of known CHF, echocardiography was often missing during in-hospital diagnostic workup after acute stroke/TIA.

Keywords: Chronic heart failure; Ischaemic stroke; Telemedical Interventional Management in Heart Failure.

PubMed Disclaimer

Conflict of interest statement

K. G. H. reports study grants by Bayer and Sanofi‐Aventis, lecture fees/advisory board fees from Bayer, Sanofi‐Aventis, Pfizer, Bristol‐Myers‐Squibb, Boehringer Ingelheim, Daiichi Sankyo, W.L. Gore & Associates, Biotronik, and Medtronic. S. T. reports lecture fees by Boehringer Ingelheim. O. D. has received personal fees and speakers' honoraria from Novartis Pharma GmbH. M. H. and K. K. have nothing to declare.

References

    1. Haeusler KG, Laufs U, Endres M. Chronic heart failure and ischemic stroke. Stroke 2011; 42: 2977–2982. - PubMed
    1. Katsanos AH, Parissis J, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Triantafyllou N, Kargiotis O, Voumvourakis K, Alexandrov AV, Tsivgoulis G. Heart failure and the risk of ischemic stroke recurrence: a systematic review and meta‐analysis. J Neurol Sci 2016; 362: 182–187. - PubMed
    1. Ferreira JP, Girerd N, Alshalash S, Konstam MA, Zannad F. Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges. Eur Heart J 2016; 37: 2455–2464. - PubMed
    1. Doehner W, Ural D, Haeusler KG, Čelutkienė J, Bestetti R, Cavusoglu Y, Peña‐Duque MA, Glavas D, Iacoviello M, Laufs U, Alvear RM, Mbakwem A, Piepoli MF, Rosen SD, Tsivgoulis G, Vitale C, Yilmaz MB, Anker SD, Filippatos G, Seferovic P, Coats AJS, Ruschitzka F. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. Eur J Heart Fail 2018; 20: 199–215. - PubMed
    1. Kristensen SL, Jhund PS, Køber L, Preiss D, Kjekshus J, McKelvie R, Zile MR, Anand IS, Wikstrand J, Wedel H, Komajda M, Carson PE, Cleland JG, McMurray J. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Eur J Heart Fail 2015; 17: 169–176. - PubMed

Publication types